09:34pm Friday 17 November 2017

Cancer patients treated in world-first clinical trial of Canadian viral therapy

The therapy was jointly discovered and is being developed by Dr. David Stojdl (Children’s Hospital of Eastern Ontario, University of Ottawa), Dr. Brian Lichty (McMaster University) and Dr. John Bell (The Ottawa Hospital, University of Ottawa), and their respective research teams and colleagues. The clinical trial, which is funded by the Ontario Institute for Cancer Research and coordinated by the NCIC Clinical Trials Group, is expected to enroll up to 79 patients at four hospitals across Canada. Up to 24 patients will receive one of the viruses and the rest will receive both, two weeks apart. 

For more information, please view the Ottawa Hospital Research Institute press release. 

Media inquiries:

Kina Leclair
Media Relations Officer
Office: 613-562-5800 (2529)
Cell: 613-762-2908


Share on:
or:

Health news